Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
The human skin blanching assay is a well established method for ranking the efficacy of corticosteroids after epicutaneous application. Vasoconstriction is a pharmacological activity, which correlates well with the clinical efficacy, the intensity of skin blanching after a single application under occlusion corresponding, generally, to the clinical efficacy after repeated application without occlusion. However, in studies dealing with the comparison between the vasoconstriction assay and the evaluation of the clinical effects on inflammatory skin diseases, some exceptions to this correlation have been reported. Therefore, in a pre-clinical phase, it would be useful to combine the blanching assay with at least one anti-inflammatory assay. In the present study the blanching assay and the allergic contact dermatitis inhibition test were performed in parallel, in order to compare the two testing procedures in the same group of subjects, utilizing standardized study designs supported by objective means of evaluation. Three commercial preparations of corticosteroids containing clobetasol propionate (CP), clobetasone butyrate (CB) and hydrocortisone acetate (HA), respectively, were employed both to treat nickel-induced positive patch test responses on the volar forearms, and to perform a vasoconstrictor assay on normal forearm skin in 16 nickel-sensitized healthy volunteers. For evaluating skin blanching, we employed colorimetric measurements, whereas for the quantitative determination of the inhibition of the intensity of allergic patch test reactions, 20 MHz B-scanning supported by image analysis was used. Both colorimetric and echogenicity values enabled us to distinguish between the three corticosteroids (at the 17 h evaluation and the 64 h assessment, respectively). A fair correlation was noted between colorimetric and echogenicity values. Both testing procedures ranked the three corticosteroids in the expected order. Corticosteroid preparations should be compared using methods which allow different effects to be simultaneously monitored, without involving a high number of patients. We are proposing this double procedure for the parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical steroids.
Seidenari
S
S
Department of Dermatology, University of Modena, Italy.
Di Nardo
A
A
Mantovani
L
L
Giannetti
A
A
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002990:Clobetasol / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D003124:Colorimetry; D017449:Dermatitis, Allergic Contact / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D004341:Drug Evaluation / Q000379:methods; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D007091:Image Processing, Computer-Assisted; D008297:Male; D009532:Nickel / Q000009:adverse effects; D010328:Patch Tests; D012867:Skin / Q000098:blood supply / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology; D014463:Ultrasonography; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D014662:Vasoconstrictor Agents; C021650:hydrocortisone acetate; D009532:Nickel; C010893:clobetasone butyrate; D002990:Clobetasol; D006854:Hydrocortisone